Insulinoma in a third-trimester pregnant woman combined with pre-eclampsia: A case report and review of the diagnostic strategies

References

• Service F J, McMahon M M, O'Brien P C, Ballard D J. Functioning insulinoma – incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin Proc 1991; 66: 711–719
   PubMed Web of Science ®Google Scholar
• Fredericks B, Entsch G, Lepre F, Nolan G, Davoren P. Pregnancy ameliorates symptoms of insulinoma – a case report. Aust N Z J Obstet Gynaecol 2002; 42: 564–565
   PubMed Web of Science ®Google Scholar
• Takacs C A, Krivak T C, Napolitano P G. Insulinoma in pregnancy: a case report and review of the literature. Obstet Gynecol Surv 2002; 57: 229–235
   PubMed Web of Science ®Google Scholar
• Garner P R, Tsang R. Insulinoma complicating pregnancy presenting with hypoglycemic coma after delivery: a case report and review of the literature. Obstet Gynecol 1989; 73: 847–849
   PubMedGoogle Scholar
• Lesser K B, Carpenter M W. Metabolic changes associated with normal pregnancy and pregnancy complicated by diabetes mellitus. Semin Perinatol 1994; 18: 399–406
   PubMedGoogle Scholar
• Magnaterra R, Porzio O, Piemonte F, Bertoli A, Sesti G, Lauro D, Marlier L N, Federici G, Borboni P. The effects of pregnancy steroids on adaptation of β cells to pregnancy involve the pancreatic glucose sensor glucokinase. J Endocrinol 1997; 155: 247–253
   PubMedGoogle Scholar
• Yamashita H, Shao J, Friedman J E. Physiologic and molecular alterations in carbohydrate metabolism during pregnancy and gestational diabetes mellitus. Clin Obstet Gynecol 2000; 43: 87–98
   PubMed Web of Science ®Google Scholar
• Freinkel N. Banting Lecture 1980. Of pregnancy and progeny. Diabetes 1980; 29: 1023–1035
   PubMed Web of Science ®Google Scholar
• Handwerger S, Freemark M. The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab 2000; 13: 343–356
   PubMed Web of Science ®Google Scholar
• Barbour L A. New concepts in insulin resistance of pregnancy and gestational diabetes: long-term implications for mother and offspring. J Obstet Gynaecol 2003; 23: 545–549
   PubMedGoogle Scholar
• Anthony R V. Placental lactogen and growth hormone: regulation and action. The endocrinology of pregnancy, F W Bazar, W Fuller. Humana Press, Totowa, NJ 1998; 461–490
   Google Scholar
• Domali E, Messinis I E. Leptin in pregnancy. J Matern Fetal Neonatal Med 2002; 12: 222–230
   PubMedGoogle Scholar
• Nakamura T, Nagasaka S, Ishikawa S, Nonaka M, Fujibayashi K, Saito T, Kusaka I, Higashiyama M, Saito T. Crucial role of insulin in leptin maintenance: profound decrease in serum leptin by octreotide acetate in insulinoma subjects. Endocr J 2000; 47: 359–364
   PubMedGoogle Scholar
• Petraglia F, Hatch M C, Lapinski R, Stomati M, Reis F M, Cobellis L, Berkowitz G S. Lack of effect of psychosocial stress on maternal corticotropin-releasing factor and catecholamine levels at 28 weeks' gestation. J Soc Gynecol Investig 2001; 8: 83–88
   PubMedGoogle Scholar
• Akanji A O, George A O, Olasode B J, Osotimehin B O. Insulinoma in pregnancy presenting as a seizure disorder: a case report. East Afr Med J 1992; 69: 117–119
   PubMedGoogle Scholar
• Hirshberg B, Livi A, Bartlett D L, Libutti S K, Alexander H R, Doppman J L, Skarulis M C, Gorden P. Forty-eight-hour fast: the diagnostic test for insulinoma. J Clin Endocrinol Metab 2000; 85: 3222–3226
   PubMed Web of Science ®Google Scholar
• Service F J, Natt N. The prolonged fast. J Clin Endocrinol Metab 2000; 85: 3973–3974
   PubMed Web of Science ®Google Scholar
• Chavan A, Kirchhoff T D, Brabant G, Scheumann G F, Wagner S, Galanski M. Role of the intra-arterial calcium stimulation test in the preoperative localization of insulinomas. Eur Radiol 2000; 10: 1582–1586
   PubMed Web of Science ®Google Scholar
• Machado M C, da Cunha J E, Jukemura J, Bacchella T, Penteado S, Abdo E E, Machado M A, Herman P, Montagnini A L, Pinotti H. Insulinoma: diagnostic strategies and surgical treatment. A 22-year experience. Hepatogastroenterology 2001; 48: 854–858
   PubMedGoogle Scholar
• Akanji A O, George A O, Olasode B J, Osotimehin B O. Fasting hypoglycaemia due to insulinoma in pregnancy. Postgrad Med J 1990; 66: 156
   PubMed Web of Science ®Google Scholar
• Owen N J, Sohaib S A, Peppercorn P D, Monson J P, Grossman A B, Besser G M, Reznek R H. MRI of pancreatic neuroendocrine tumours. Br J Radiol 2001; 74: 968–973
   PubMed Web of Science ®Google Scholar
• Ardengh J C, Rosenbaum P, Ganc A J, Goldenberg A, Lobo E J, Malheiros C A, Rahal F, Ferrari A P. Role of EUS in the preoperative localization of insulinomas compared with spiral CT. Gastrointest Endosc 2000; 51: 552–555
   PubMed Web of Science ®Google Scholar
• Nesje L B, Varhaug J E, Husebye E S, Odegaard S. Endoscopic ultrasonography for preoperative diagnosis and localization of insulinomas. Scand J Gastroenterol 2002; 37: 732–737
   PubMed Web of Science ®Google Scholar
• Brandle M, Pfammatter T, Spinas G A, Lehmann R, Schmid C. Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours. Clin Endocrinol (Oxf) 2001; 55: 357–362
   PubMedGoogle Scholar
• Kaltsas G, Korbonits M, Heintz E, Mukherjee J J, Jenkins P J, Chew S L, Reznek R, Monson J P, Besser G M, Foley R, et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 2001; 86: 895–902
   PubMed Web of Science ®Google Scholar
• Warner R R, O'dorisio T M. Radiolabeled peptides in diagnosis and tumor imaging: clinical overview. Semin Nucl Med 2002; 32: 79–83
   PubMedGoogle Scholar
• Kwekkeboom D J, Krenning E P. Somatostatin receptor imaging. Semin Nucl Med 2002; 32: 84–91
   PubMed Web of Science ®Google Scholar
• Ichijo T, Ishikawa M, Shimojo M, Tsubuku M, Tsuboi K, Miyachi Y. Role of (111)In-DTPA-pentetreotide scintigraphy in accurate diagnosis of neuroendocrine gastroenteropancreatic tumors. J Hepatobiliary Pancreat Surg 2001; 8: 473–478
   PubMedGoogle Scholar
• Briganti V, Matteini M, Ferri P, Vaggelli L, Castagnoli A, Pieroni C. Octreoscan SPET evaluation in the diagnosis of pancreas neuroendocrine tumors. Cancer Biother Radiopharm 2001; 16: 515–524
   PubMedGoogle Scholar
• Lebtahi R, Le Cloirec J, Houzard C, Daou D, Sobhani I, Sassolas G, Mignon M, Bourguet P, Le Guludec D. Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy. J Nucl Med 2002; 43: 889–895
   PubMed Web of Science ®Google Scholar
• Le Duc-Pennec A, Thol C, Cavarec M, Le Rest C, Turzo A, Guillo P, Bizais Y. Octreotide imaging plus bone scintigrams to optimally localize gastroenteropancreatic neuroendocrine tumors. Clin Nucl Med 2003; 28: 5–8
   PubMedGoogle Scholar
• Cogliandolo A, Pidoto R R, Causse X, Kerdraon R, Saint M O. Minimally invasive management of insulinomas. A case report. Surg Endosc 2001; 15: 1042
   PubMedGoogle Scholar